??n kho?ng 13h40 cùng ngày.

and provide new services; enhance the development of generics and bioequivalents; and build and equip modern tech equipment.the firm focused on strongly making investment in research and development of new products.

photo Le ToanAccording to the company.which started construction in 2022.the company will focus on reviewing and rebuilding the overall policy for OTC sales; increase investment in activities to develop new western medicines.

or special treatment segments are mostly in the hands of foreign-invested enterprises.VDSC added that the OTC channel will decelerate in 2024.

it made revenues of over $211 million and a profit of $49.

Imexpharm became the first company to meet GMP-ASEAN standards in Vietnam.said: The markets for the districts giant river prawns are mostly in HCM City.

compared to the previous week.Its project of growing coconut under organic methods in combination with guaranteed outlets to serve domestic and export markets is being implemented on 152.

according to the Gò C?ng Tay District Farmers Association.new Covid-19 variants along with acute respiratory distress agents.